BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 755032)

  • 1. The diagnostic potential of contrast enhancement pharmacokinetics.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1978; 13(6):533-40. PubMed ID: 755032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhancement: diagnostic significance from a statistical viewpoint.
    Dean PB; Kivisaari L; Kormano M
    J Comput Assist Tomogr; 1978 Jul; 2(3):314-8. PubMed ID: 263497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. I. The renal cortex.
    Brennan RE; Curtis JA; Pollack HM; Weinberg I
    Invest Radiol; 1979; 14(2):141-8. PubMed ID: 478803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extravascular contrast material: the major component of contrast enhancement.
    Kormano M; Dean PB
    Radiology; 1976 Nov; 121(2):379-82. PubMed ID: 981616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diatrizoate CT distribution kinetics: a study of human tissue characterization.
    Oppenheimer DA; Young SW
    J Comput Assist Tomogr; 1983 Apr; 7(2):274-7. PubMed ID: 6833559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast media in body computed tomography: experimental and theoretical background background, present limitations, and proposals for improved diagnostic efficacy.
    Dean PB
    Invest Radiol; 1980; 15(6 Suppl):S164-9. PubMed ID: 7203918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion.
    Dean PB; Violante MR; Mahoney JA
    Invest Radiol; 1980; 15(2):158-61. PubMed ID: 7372426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress.
    Ryan PJ; Davis MA; DeGaeta LR; Woda B; Melchior DL
    Radiology; 1984 Sep; 152(3):759-62. PubMed ID: 6611564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhancement in abdominal CT: bolus vs. infusion.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1981 Aug; 137(2):351-8. PubMed ID: 6789645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic computed tomography time--density study of normal human tissue after intravenous contrast administration.
    Young SW; Noon MA; Marincek B
    Invest Radiol; 1981; 16(1):36-9. PubMed ID: 7216694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enhancement technique for dynamic hepatic computed tomographic scanning.
    Foley WD; Berland LL; Lawson TL; Smith DF; Thorsen MK
    Radiology; 1983 Jun; 147(3):797-803. PubMed ID: 6844616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.
    Henning T; Weber AW; Bauer JS; Meier R; Carlsen JM; Sutton EJ; Prevrhal S; Ziegler SI; Feussner H; Daldrup-Link HE; Rummeny EJ
    Acad Radiol; 2008 Mar; 15(3):342-9. PubMed ID: 18280932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial bolus of 125I labeled meglumine diatrizoate. Early extravascular distribution.
    Dean PB; Kormano M
    Acta Radiol Diagn (Stockh); 1977 Jul; 18(4):425-32. PubMed ID: 920233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
    Brook OR; Gourtsoyianni S; Brook A; Siewert B; Kent T; Raptopoulos V
    Radiology; 2013 Oct; 269(1):139-48. PubMed ID: 23674791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of myocardial contrast enhancement: an in vivo computed-tomographic study.
    Cipriano PR; Nassi M; Brody WR
    Radiology; 1981 Sep; 140(3):823-6. PubMed ID: 7280253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.
    Bae KT; Shah AJ; Shang SS; Wang JH; Chang S; Kanematsu M; Hildebolt CF
    AJR Am J Roentgenol; 2008 Nov; 191(5):1589-94. PubMed ID: 18941106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.